Literature DB >> 2039829

Homing and progression patterns of childhood acute lymphoblastic leukemias in severe combined immunodeficiency mice.

A Cesano1, R O'Connor, B Lange, J Finan, G Rovera, D Santoli.   

Abstract

The aim of this study was to analyze the homing and progression patterns of childhood acute lymphoblastic leukemias (ALL) in mice with severe combined immunodeficiency (SCID). Upon intraperitoneal (IP) transfer, cells from relapse samples of three children with T-lineage ALL spread hematogenously and infiltrated the non-lymphoid and/or lymphoid organs with a pattern reminiscent of the human clinical disease. These mice either died or were killed in extremis at a mean of 9 weeks. Moreover, cell lines established in vitro from two of these samples manifested identical homing and progression in the SCID mouse as compared with the original patients' cells. Thus, long-term culture of the primary leukemic T cells did not alter their invasive potential and migration pattern. When engrafted IP, three cell lines established from pre-B-ALL cases displayed primarily a lymphatic spread with induction of local tumor masses and kidney/liver nodules. Mice were killed at 11 to 13 weeks, but had not developed imminently fatal leukemia. However, when transferred intravenously, one pre-B ALL cell line was able to spread hematogenously and to infiltrate both lymphoid and non-lymphoid tissues. Overall, these data demonstrate that the SCID mouse provides an efficient and reproducible model to study the pathogenesis of childhood ALL, and may be a suitable system for evaluating therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039829

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Authors:  David M Barrett; Alix E Seif; Carmine Carpenito; David T Teachey; Jonathan D Fish; Carl H June; Stephan A Grupp; Gregor S D Reid
Journal:  Blood       Date:  2011-08-19       Impact factor: 22.113

3.  A human monoclonal antibody which inhibits the coaggregation activity of Porphyromonas gingivalis.

Authors:  Y Abiko; N Ogura; U Matsuda; K Yanagi; H Takiguchi
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

4.  Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.

Authors:  A Cesano; S Visonneau; L Cioé; S C Clark; G Rovera; D Santoli
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.

Authors:  M Hsiao; J Low; E Dorn; D Ku; P Pattengale; J Yeargin; M Haas
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

6.  Two unique human leukemic T-cell lines endowed with a stable cytotoxic function and a different spectrum of target reactivity analysis and modulation of their lytic mechanisms.

Authors:  A Cesano; D Santoli
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

7.  Effects of lethal irradiation and cyclosporin A treatment on the growth and tumoricidal activity of a T cell clone potentially useful in cancer therapy.

Authors:  A Cesano; S Visonneau; L Cioé; S C Clark; D Santoli
Journal:  Cancer Immunol Immunother       Date:  1995-03       Impact factor: 6.968

8.  Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.

Authors:  G Feuer; S A Stewart; S M Baird; F Lee; R Feuer; I S Chen
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Immunotoxin studies in a model of human T-cell acute lymphoblastic leukemia developed in severe combined immune-deficient mice.

Authors:  B J Morland; D Boehm; S U Flavell; J A Kohler; D J Flavell
Journal:  Cell Biophys       Date:  1994

10.  Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice.

Authors:  B J Morland; J Barley; D Boehm; S U Flavell; N Ghaleb; J A Kohler; K Okayama; B Wilkins; D J Flavell
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.